XML 31 R67.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation Level 4 (Details) (USD $)
3 Months Ended
Mar. 31, 2012
Stock Options [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Dividend yield 1.80%
Expected volatility 40.80%
Risk-free interest rate 0.80%
Expected holding period 5.0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding at beginning of period 13,404,216
Options outstanding at beginning of period, weighted average exercise price $ 7.88
Granted 2,023,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 11.18
Exercised 422,234
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 5.50
Options outstanding at end of period 15,005,482
Options outstanding at end of period, weighted average exercise price $ 8.40
Options exercisable at March 31, 2012 10,642,843
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 7.82
Restricted Stock [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Nonvested restricted shares at beginning of period 1,165,170
Nonvested restricted shares at beginning of period, weighted average grant date fair value $ 7.53
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 483,170
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 11.18
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 520,161
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 6.05
Nonvested restricted shares at end of period 1,128,179
Nonvested restricted shares at end of period, weighted average grant date fair value $ 9.78